
FDA backs the benefits of adopting continuous manufacturing, a strategy which has accelerated approval and launch timelines, and its Emerging Technology Program could be a helpful tool.
Director of Science Staff, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA
Published: September 9th 2022 | Updated: